课题基金 / 基金详情

IMMUNOGENICITY & EFFICACY OF DNA VACCINES AGAINST SIV INFECTION

IMMUNOGENICITY & EFFICACY OF DNA VACCINES AGAINST SIV INFECTION
免疫原性
批准号：
7959065
负责人：
George N. Pavlakis
金额：
$10.99万
依托单位：
UNIVERSITY OF CALIFORNIA AT DAVIS
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-05-01 至 2010-04-30
来源：
https://reporter.nih.gov/project-details/7959065
关键词：
CaliforniaComputer Retrieval of Information on Scientific Projects DatabaseDNA VaccinesFundingGrantHIVHIV InfectionsHIV vaccineInfectionInstitutionMacaca mulattaModelingPrimatesProteinsResearchResearch PersonnelResourcesSIVSourceTestingUnited States National Institutes of Healthimmunogenicitynovelpandemic disease

项目摘要

项目成果

George N. Pavlakis的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. There is an urgent need for an HIV vaccine that can reduce the HIV pandemic. Novel DNA vaccines that express SIV proteins are tested for immunogenicity and efficacy in the SIV-rhesus macaque model of HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV Molecular Biology and DNA Vaccine Approaches Against
COVID-19 vaccine development
  • 批准号：
    10487068
  • 项目类别：
  • 资助金额：
    $66.18万
  • 财政年份：
    --
  • 负责人：
    George N. Pavlakis
  • 依托单位：
    DIVISION OF BASIC SCIENCES - NCI
Heterodimeric IL-15 in Cancer Immunotherapy
  • 批准号：
    10262144
  • 项目类别：
  • 资助金额：
    $194.36万
  • 财政年份：
    --
  • 负责人：
    George N. Pavlakis
  • 依托单位：
    DIVISION OF BASIC SCIENCES - NCI
DNA Vaccines
  • 批准号：
    8157430
  • 项目类别：
  • 资助金额：
    $195.2万
  • 财政年份：
    --
  • 负责人：
    George N. Pavlakis
  • 依托单位：
    DIVISION OF BASIC SCIENCES - NCI